GSK (GSK) Filings

6-K

GSK GSK Plc

27 Mar 23

Publication of 2023 Agm Notice

8:51am

6-K

GSK GSK Plc

24 Mar 23

Statement: Zantac (Ranitidine) Litigation

8:29am

6-K

GSK GSK Plc

21 Mar 23

Director/pdmr Shareholding

11:36am

6-K

GSK GSK Plc

20 Mar 23

Director/pdmr Shareholding

11:41am

EFFECT

Glaxosmithkline Capital Inc

16 Mar 23

Notice of effectiveness

12:15am

6-K

GSK GSK Plc

14 Mar 23

Positive Phase III Results for Menabcwy Vaccine

7:11am

6-K

GSK GSK Plc

14 Mar 23

Nucala Nda Accepted for Review In China

7:04am

6-K

GSK GSK Plc

13 Mar 23

Director/pdmr Shareholding

11:39am

POS AM

Glaxosmithkline Capital Inc

10 Mar 23

Prospectus update (post-effective amendment)

12:20pm

6-K

GSK GSK Plc

10 Mar 23

GSK Annual Report 2022 on Form 20-F

12:16pm

IRAN

GSK GSK Plc

10 Mar 23

Disclosure regarding Iran Threat Reduction and Syria Human Rights Act

11:22am

6-K

GSK GSK Plc

10 Mar 23

GSK Publishes Annual Report 2022

6:53am

6-K

GSK GSK Plc

2 Mar 23

Fda Ad Com Votes to Support GSK RSV Oa Vaccine

6:33am

6-K

GSK GSK Plc

1 Mar 23

Total Voting Rights

12:05pm

6-K

GSK GSK Plc

27 Feb 23

Director/pdmr Shareholding

11:12am

6-K

GSK GSK Plc

23 Feb 23

Director/pdmr Shareholding

10:36am

6-K

GSK GSK Plc

23 Feb 23

VIIV Healthcare Announces Cabenuva Positive Data

6:22am

6-K

GSK GSK Plc

22 Feb 23

Director/pdmr Shareholding

12:37pm

6-K

GSK GSK Plc

16 Feb 23

Nejm Publishes GSK RSV Oa Vaccine Candidate Trial

7:19am